Global Gliclazide Sustained-release Tablet Market Research Report 2024(Status and Outlook)

Report Overview
This report provides a deep insight into the global Gliclazide Sustained-release Tablet market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gliclazide Sustained-release Tablet Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gliclazide Sustained-release Tablet market in any manner.
Global Gliclazide Sustained-release Tablet Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Servier Laboratories
Torrent Pharmaceuticals
Aurobindo Pharma
Teva
Zydus Cadila Healthcare
Sanofi S.A.
Mylan Pharmaceuticals
Accord Healthcare
Lukang Jituan Saite Yaoye
Shijiazhuang SIYAO
Yiling Pharmaceutical
Market Segmentation (by Type)
30mg
60mg
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gliclazide Sustained-release Tablet Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Gliclazide Sustained-release Tablet market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gliclazide Sustained-release Tablet Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gliclazide Sustained-release Tablet market in any manner.
Global Gliclazide Sustained-release Tablet Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Servier Laboratories
Torrent Pharmaceuticals
Aurobindo Pharma
Teva
Zydus Cadila Healthcare
Sanofi S.A.
Mylan Pharmaceuticals
Accord Healthcare
Lukang Jituan Saite Yaoye
Shijiazhuang SIYAO
Yiling Pharmaceutical
Market Segmentation (by Type)
30mg
60mg
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gliclazide Sustained-release Tablet Market
- Overview of the regional outlook of the Gliclazide Sustained-release Tablet Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gliclazide Sustained-release Tablet Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gliclazide Sustained-release Tablet
1.2 Key Market Segments
1.2.1 Gliclazide Sustained-release Tablet Segment by Type
1.2.2 Gliclazide Sustained-release Tablet Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gliclazide Sustained-release Tablet Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gliclazide Sustained-release Tablet Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET COMPETITIVE LANDSCAPE
3.1 Global Gliclazide Sustained-release Tablet Sales by Manufacturers (2019-2024)
3.2 Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2019-2024)
3.3 Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gliclazide Sustained-release Tablet Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gliclazide Sustained-release Tablet Sales Sites, Area Served, Product Type
3.6 Gliclazide Sustained-release Tablet Market Competitive Situation and Trends
3.6.1 Gliclazide Sustained-release Tablet Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gliclazide Sustained-release Tablet Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GLICLAZIDE SUSTAINED-RELEASE TABLET INDUSTRY CHAIN ANALYSIS
4.1 Gliclazide Sustained-release Tablet Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2019-2024)
6.3 Global Gliclazide Sustained-release Tablet Market Size Market Share by Type (2019-2024)
6.4 Global Gliclazide Sustained-release Tablet Price by Type (2019-2024)
7 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gliclazide Sustained-release Tablet Market Sales by Application (2019-2024)
7.3 Global Gliclazide Sustained-release Tablet Market Size (M USD) by Application (2019-2024)
7.4 Global Gliclazide Sustained-release Tablet Sales Growth Rate by Application (2019-2024)
8 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET SEGMENTATION BY REGION
8.1 Global Gliclazide Sustained-release Tablet Sales by Region
8.1.1 Global Gliclazide Sustained-release Tablet Sales by Region
8.1.2 Global Gliclazide Sustained-release Tablet Sales Market Share by Region
8.2 North America
8.2.1 North America Gliclazide Sustained-release Tablet Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gliclazide Sustained-release Tablet Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gliclazide Sustained-release Tablet Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gliclazide Sustained-release Tablet Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gliclazide Sustained-release Tablet Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Servier Laboratories
9.1.1 Servier Laboratories Gliclazide Sustained-release Tablet Basic Information
9.1.2 Servier Laboratories Gliclazide Sustained-release Tablet Product Overview
9.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Product Market Performance
9.1.4 Servier Laboratories Business Overview
9.1.5 Servier Laboratories Gliclazide Sustained-release Tablet SWOT Analysis
9.1.6 Servier Laboratories Recent Developments
9.2 Torrent Pharmaceuticals
9.2.1 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
9.2.2 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
9.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Market Performance
9.2.4 Torrent Pharmaceuticals Business Overview
9.2.5 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet SWOT Analysis
9.2.6 Torrent Pharmaceuticals Recent Developments
9.3 Aurobindo Pharma
9.3.1 Aurobindo Pharma Gliclazide Sustained-release Tablet Basic Information
9.3.2 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Overview
9.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Market Performance
9.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet SWOT Analysis
9.3.5 Aurobindo Pharma Business Overview
9.3.6 Aurobindo Pharma Recent Developments
9.4 Teva
9.4.1 Teva Gliclazide Sustained-release Tablet Basic Information
9.4.2 Teva Gliclazide Sustained-release Tablet Product Overview
9.4.3 Teva Gliclazide Sustained-release Tablet Product Market Performance
9.4.4 Teva Business Overview
9.4.5 Teva Recent Developments
9.5 Zydus Cadila Healthcare
9.5.1 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Basic Information
9.5.2 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Overview
9.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Market Performance
9.5.4 Zydus Cadila Healthcare Business Overview
9.5.5 Zydus Cadila Healthcare Recent Developments
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Gliclazide Sustained-release Tablet Basic Information
9.6.2 Sanofi S.A. Gliclazide Sustained-release Tablet Product Overview
9.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Product Market Performance
9.6.4 Sanofi S.A. Business Overview
9.6.5 Sanofi S.A. Recent Developments
9.7 Mylan Pharmaceuticals
9.7.1 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
9.7.2 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
9.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Market Performance
9.7.4 Mylan Pharmaceuticals Business Overview
9.7.5 Mylan Pharmaceuticals Recent Developments
9.8 Accord Healthcare
9.8.1 Accord Healthcare Gliclazide Sustained-release Tablet Basic Information
9.8.2 Accord Healthcare Gliclazide Sustained-release Tablet Product Overview
9.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Product Market Performance
9.8.4 Accord Healthcare Business Overview
9.8.5 Accord Healthcare Recent Developments
9.9 Lukang Jituan Saite Yaoye
9.9.1 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Basic Information
9.9.2 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Overview
9.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Market Performance
9.9.4 Lukang Jituan Saite Yaoye Business Overview
9.9.5 Lukang Jituan Saite Yaoye Recent Developments
9.10 Shijiazhuang SIYAO
9.10.1 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Basic Information
9.10.2 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Overview
9.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Market Performance
9.10.4 Shijiazhuang SIYAO Business Overview
9.10.5 Shijiazhuang SIYAO Recent Developments
9.11 Yiling Pharmaceutical
9.11.1 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Basic Information
9.11.2 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Overview
9.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Market Performance
9.11.4 Yiling Pharmaceutical Business Overview
9.11.5 Yiling Pharmaceutical Recent Developments
10 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET FORECAST BY REGION
10.1 Global Gliclazide Sustained-release Tablet Market Size Forecast
10.2 Global Gliclazide Sustained-release Tablet Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gliclazide Sustained-release Tablet Market Size Forecast by Country
10.2.3 Asia Pacific Gliclazide Sustained-release Tablet Market Size Forecast by Region
10.2.4 South America Gliclazide Sustained-release Tablet Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gliclazide Sustained-release Tablet by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gliclazide Sustained-release Tablet Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gliclazide Sustained-release Tablet by Type (2025-2030)
11.1.2 Global Gliclazide Sustained-release Tablet Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gliclazide Sustained-release Tablet by Type (2025-2030)
11.2 Global Gliclazide Sustained-release Tablet Market Forecast by Application (2025-2030)
11.2.1 Global Gliclazide Sustained-release Tablet Sales (Kilotons) Forecast by Application
11.2.2 Global Gliclazide Sustained-release Tablet Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gliclazide Sustained-release Tablet
1.2 Key Market Segments
1.2.1 Gliclazide Sustained-release Tablet Segment by Type
1.2.2 Gliclazide Sustained-release Tablet Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gliclazide Sustained-release Tablet Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gliclazide Sustained-release Tablet Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET COMPETITIVE LANDSCAPE
3.1 Global Gliclazide Sustained-release Tablet Sales by Manufacturers (2019-2024)
3.2 Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2019-2024)
3.3 Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gliclazide Sustained-release Tablet Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gliclazide Sustained-release Tablet Sales Sites, Area Served, Product Type
3.6 Gliclazide Sustained-release Tablet Market Competitive Situation and Trends
3.6.1 Gliclazide Sustained-release Tablet Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gliclazide Sustained-release Tablet Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GLICLAZIDE SUSTAINED-RELEASE TABLET INDUSTRY CHAIN ANALYSIS
4.1 Gliclazide Sustained-release Tablet Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2019-2024)
6.3 Global Gliclazide Sustained-release Tablet Market Size Market Share by Type (2019-2024)
6.4 Global Gliclazide Sustained-release Tablet Price by Type (2019-2024)
7 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gliclazide Sustained-release Tablet Market Sales by Application (2019-2024)
7.3 Global Gliclazide Sustained-release Tablet Market Size (M USD) by Application (2019-2024)
7.4 Global Gliclazide Sustained-release Tablet Sales Growth Rate by Application (2019-2024)
8 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET SEGMENTATION BY REGION
8.1 Global Gliclazide Sustained-release Tablet Sales by Region
8.1.1 Global Gliclazide Sustained-release Tablet Sales by Region
8.1.2 Global Gliclazide Sustained-release Tablet Sales Market Share by Region
8.2 North America
8.2.1 North America Gliclazide Sustained-release Tablet Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gliclazide Sustained-release Tablet Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gliclazide Sustained-release Tablet Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gliclazide Sustained-release Tablet Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gliclazide Sustained-release Tablet Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Servier Laboratories
9.1.1 Servier Laboratories Gliclazide Sustained-release Tablet Basic Information
9.1.2 Servier Laboratories Gliclazide Sustained-release Tablet Product Overview
9.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Product Market Performance
9.1.4 Servier Laboratories Business Overview
9.1.5 Servier Laboratories Gliclazide Sustained-release Tablet SWOT Analysis
9.1.6 Servier Laboratories Recent Developments
9.2 Torrent Pharmaceuticals
9.2.1 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
9.2.2 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
9.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Market Performance
9.2.4 Torrent Pharmaceuticals Business Overview
9.2.5 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet SWOT Analysis
9.2.6 Torrent Pharmaceuticals Recent Developments
9.3 Aurobindo Pharma
9.3.1 Aurobindo Pharma Gliclazide Sustained-release Tablet Basic Information
9.3.2 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Overview
9.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Market Performance
9.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet SWOT Analysis
9.3.5 Aurobindo Pharma Business Overview
9.3.6 Aurobindo Pharma Recent Developments
9.4 Teva
9.4.1 Teva Gliclazide Sustained-release Tablet Basic Information
9.4.2 Teva Gliclazide Sustained-release Tablet Product Overview
9.4.3 Teva Gliclazide Sustained-release Tablet Product Market Performance
9.4.4 Teva Business Overview
9.4.5 Teva Recent Developments
9.5 Zydus Cadila Healthcare
9.5.1 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Basic Information
9.5.2 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Overview
9.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Market Performance
9.5.4 Zydus Cadila Healthcare Business Overview
9.5.5 Zydus Cadila Healthcare Recent Developments
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Gliclazide Sustained-release Tablet Basic Information
9.6.2 Sanofi S.A. Gliclazide Sustained-release Tablet Product Overview
9.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Product Market Performance
9.6.4 Sanofi S.A. Business Overview
9.6.5 Sanofi S.A. Recent Developments
9.7 Mylan Pharmaceuticals
9.7.1 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
9.7.2 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
9.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Market Performance
9.7.4 Mylan Pharmaceuticals Business Overview
9.7.5 Mylan Pharmaceuticals Recent Developments
9.8 Accord Healthcare
9.8.1 Accord Healthcare Gliclazide Sustained-release Tablet Basic Information
9.8.2 Accord Healthcare Gliclazide Sustained-release Tablet Product Overview
9.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Product Market Performance
9.8.4 Accord Healthcare Business Overview
9.8.5 Accord Healthcare Recent Developments
9.9 Lukang Jituan Saite Yaoye
9.9.1 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Basic Information
9.9.2 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Overview
9.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Market Performance
9.9.4 Lukang Jituan Saite Yaoye Business Overview
9.9.5 Lukang Jituan Saite Yaoye Recent Developments
9.10 Shijiazhuang SIYAO
9.10.1 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Basic Information
9.10.2 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Overview
9.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Market Performance
9.10.4 Shijiazhuang SIYAO Business Overview
9.10.5 Shijiazhuang SIYAO Recent Developments
9.11 Yiling Pharmaceutical
9.11.1 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Basic Information
9.11.2 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Overview
9.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Market Performance
9.11.4 Yiling Pharmaceutical Business Overview
9.11.5 Yiling Pharmaceutical Recent Developments
10 GLICLAZIDE SUSTAINED-RELEASE TABLET MARKET FORECAST BY REGION
10.1 Global Gliclazide Sustained-release Tablet Market Size Forecast
10.2 Global Gliclazide Sustained-release Tablet Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gliclazide Sustained-release Tablet Market Size Forecast by Country
10.2.3 Asia Pacific Gliclazide Sustained-release Tablet Market Size Forecast by Region
10.2.4 South America Gliclazide Sustained-release Tablet Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gliclazide Sustained-release Tablet by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gliclazide Sustained-release Tablet Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gliclazide Sustained-release Tablet by Type (2025-2030)
11.1.2 Global Gliclazide Sustained-release Tablet Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gliclazide Sustained-release Tablet by Type (2025-2030)
11.2 Global Gliclazide Sustained-release Tablet Market Forecast by Application (2025-2030)
11.2.1 Global Gliclazide Sustained-release Tablet Sales (Kilotons) Forecast by Application
11.2.2 Global Gliclazide Sustained-release Tablet Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gliclazide Sustained-release Tablet Market Size Comparison by Region (M USD)
Table 5. Global Gliclazide Sustained-release Tablet Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gliclazide Sustained-release Tablet Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gliclazide Sustained-release Tablet as of 2022)
Table 10. Global Market Gliclazide Sustained-release Tablet Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gliclazide Sustained-release Tablet Sales Sites and Area Served
Table 12. Manufacturers Gliclazide Sustained-release Tablet Product Type
Table 13. Global Gliclazide Sustained-release Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gliclazide Sustained-release Tablet
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gliclazide Sustained-release Tablet Market Challenges
Table 22. Global Gliclazide Sustained-release Tablet Sales by Type (Kilotons)
Table 23. Global Gliclazide Sustained-release Tablet Market Size by Type (M USD)
Table 24. Global Gliclazide Sustained-release Tablet Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2019-2024)
Table 26. Global Gliclazide Sustained-release Tablet Market Size (M USD) by Type (2019-2024)
Table 27. Global Gliclazide Sustained-release Tablet Market Size Share by Type (2019-2024)
Table 28. Global Gliclazide Sustained-release Tablet Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gliclazide Sustained-release Tablet Sales (Kilotons) by Application
Table 30. Global Gliclazide Sustained-release Tablet Market Size by Application
Table 31. Global Gliclazide Sustained-release Tablet Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2019-2024)
Table 33. Global Gliclazide Sustained-release Tablet Sales by Application (2019-2024) & (M USD)
Table 34. Global Gliclazide Sustained-release Tablet Market Share by Application (2019-2024)
Table 35. Global Gliclazide Sustained-release Tablet Sales Growth Rate by Application (2019-2024)
Table 36. Global Gliclazide Sustained-release Tablet Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2019-2024)
Table 38. North America Gliclazide Sustained-release Tablet Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gliclazide Sustained-release Tablet Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gliclazide Sustained-release Tablet Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gliclazide Sustained-release Tablet Sales by Region (2019-2024) & (Kilotons)
Table 43. Servier Laboratories Gliclazide Sustained-release Tablet Basic Information
Table 44. Servier Laboratories Gliclazide Sustained-release Tablet Product Overview
Table 45. Servier Laboratories Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Servier Laboratories Business Overview
Table 47. Servier Laboratories Gliclazide Sustained-release Tablet SWOT Analysis
Table 48. Servier Laboratories Recent Developments
Table 49. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
Table 50. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
Table 51. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Torrent Pharmaceuticals Business Overview
Table 53. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet SWOT Analysis
Table 54. Torrent Pharmaceuticals Recent Developments
Table 55. Aurobindo Pharma Gliclazide Sustained-release Tablet Basic Information
Table 56. Aurobindo Pharma Gliclazide Sustained-release Tablet Product Overview
Table 57. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Aurobindo Pharma Gliclazide Sustained-release Tablet SWOT Analysis
Table 59. Aurobindo Pharma Business Overview
Table 60. Aurobindo Pharma Recent Developments
Table 61. Teva Gliclazide Sustained-release Tablet Basic Information
Table 62. Teva Gliclazide Sustained-release Tablet Product Overview
Table 63. Teva Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teva Business Overview
Table 65. Teva Recent Developments
Table 66. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Basic Information
Table 67. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Overview
Table 68. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Zydus Cadila Healthcare Business Overview
Table 70. Zydus Cadila Healthcare Recent Developments
Table 71. Sanofi S.A. Gliclazide Sustained-release Tablet Basic Information
Table 72. Sanofi S.A. Gliclazide Sustained-release Tablet Product Overview
Table 73. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sanofi S.A. Business Overview
Table 75. Sanofi S.A. Recent Developments
Table 76. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
Table 77. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
Table 78. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Mylan Pharmaceuticals Business Overview
Table 80. Mylan Pharmaceuticals Recent Developments
Table 81. Accord Healthcare Gliclazide Sustained-release Tablet Basic Information
Table 82. Accord Healthcare Gliclazide Sustained-release Tablet Product Overview
Table 83. Accord Healthcare Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Accord Healthcare Business Overview
Table 85. Accord Healthcare Recent Developments
Table 86. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Basic Information
Table 87. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Overview
Table 88. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lukang Jituan Saite Yaoye Business Overview
Table 90. Lukang Jituan Saite Yaoye Recent Developments
Table 91. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Basic Information
Table 92. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Overview
Table 93. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shijiazhuang SIYAO Business Overview
Table 95. Shijiazhuang SIYAO Recent Developments
Table 96. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Basic Information
Table 97. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Overview
Table 98. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Yiling Pharmaceutical Business Overview
Table 100. Yiling Pharmaceutical Recent Developments
Table 101. Global Gliclazide Sustained-release Tablet Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Gliclazide Sustained-release Tablet Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Gliclazide Sustained-release Tablet Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Gliclazide Sustained-release Tablet Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Gliclazide Sustained-release Tablet Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Gliclazide Sustained-release Tablet Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Gliclazide Sustained-release Tablet Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Gliclazide Sustained-release Tablet Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Gliclazide Sustained-release Tablet Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Gliclazide Sustained-release Tablet Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Gliclazide Sustained-release Tablet Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Gliclazide Sustained-release Tablet Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Gliclazide Sustained-release Tablet Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gliclazide Sustained-release Tablet Market Size Comparison by Region (M USD)
Table 5. Global Gliclazide Sustained-release Tablet Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gliclazide Sustained-release Tablet Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gliclazide Sustained-release Tablet as of 2022)
Table 10. Global Market Gliclazide Sustained-release Tablet Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gliclazide Sustained-release Tablet Sales Sites and Area Served
Table 12. Manufacturers Gliclazide Sustained-release Tablet Product Type
Table 13. Global Gliclazide Sustained-release Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gliclazide Sustained-release Tablet
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gliclazide Sustained-release Tablet Market Challenges
Table 22. Global Gliclazide Sustained-release Tablet Sales by Type (Kilotons)
Table 23. Global Gliclazide Sustained-release Tablet Market Size by Type (M USD)
Table 24. Global Gliclazide Sustained-release Tablet Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2019-2024)
Table 26. Global Gliclazide Sustained-release Tablet Market Size (M USD) by Type (2019-2024)
Table 27. Global Gliclazide Sustained-release Tablet Market Size Share by Type (2019-2024)
Table 28. Global Gliclazide Sustained-release Tablet Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gliclazide Sustained-release Tablet Sales (Kilotons) by Application
Table 30. Global Gliclazide Sustained-release Tablet Market Size by Application
Table 31. Global Gliclazide Sustained-release Tablet Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2019-2024)
Table 33. Global Gliclazide Sustained-release Tablet Sales by Application (2019-2024) & (M USD)
Table 34. Global Gliclazide Sustained-release Tablet Market Share by Application (2019-2024)
Table 35. Global Gliclazide Sustained-release Tablet Sales Growth Rate by Application (2019-2024)
Table 36. Global Gliclazide Sustained-release Tablet Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2019-2024)
Table 38. North America Gliclazide Sustained-release Tablet Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gliclazide Sustained-release Tablet Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gliclazide Sustained-release Tablet Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gliclazide Sustained-release Tablet Sales by Region (2019-2024) & (Kilotons)
Table 43. Servier Laboratories Gliclazide Sustained-release Tablet Basic Information
Table 44. Servier Laboratories Gliclazide Sustained-release Tablet Product Overview
Table 45. Servier Laboratories Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Servier Laboratories Business Overview
Table 47. Servier Laboratories Gliclazide Sustained-release Tablet SWOT Analysis
Table 48. Servier Laboratories Recent Developments
Table 49. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
Table 50. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
Table 51. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Torrent Pharmaceuticals Business Overview
Table 53. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet SWOT Analysis
Table 54. Torrent Pharmaceuticals Recent Developments
Table 55. Aurobindo Pharma Gliclazide Sustained-release Tablet Basic Information
Table 56. Aurobindo Pharma Gliclazide Sustained-release Tablet Product Overview
Table 57. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Aurobindo Pharma Gliclazide Sustained-release Tablet SWOT Analysis
Table 59. Aurobindo Pharma Business Overview
Table 60. Aurobindo Pharma Recent Developments
Table 61. Teva Gliclazide Sustained-release Tablet Basic Information
Table 62. Teva Gliclazide Sustained-release Tablet Product Overview
Table 63. Teva Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Teva Business Overview
Table 65. Teva Recent Developments
Table 66. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Basic Information
Table 67. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Overview
Table 68. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Zydus Cadila Healthcare Business Overview
Table 70. Zydus Cadila Healthcare Recent Developments
Table 71. Sanofi S.A. Gliclazide Sustained-release Tablet Basic Information
Table 72. Sanofi S.A. Gliclazide Sustained-release Tablet Product Overview
Table 73. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sanofi S.A. Business Overview
Table 75. Sanofi S.A. Recent Developments
Table 76. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Basic Information
Table 77. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Overview
Table 78. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Mylan Pharmaceuticals Business Overview
Table 80. Mylan Pharmaceuticals Recent Developments
Table 81. Accord Healthcare Gliclazide Sustained-release Tablet Basic Information
Table 82. Accord Healthcare Gliclazide Sustained-release Tablet Product Overview
Table 83. Accord Healthcare Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Accord Healthcare Business Overview
Table 85. Accord Healthcare Recent Developments
Table 86. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Basic Information
Table 87. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Overview
Table 88. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Lukang Jituan Saite Yaoye Business Overview
Table 90. Lukang Jituan Saite Yaoye Recent Developments
Table 91. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Basic Information
Table 92. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Overview
Table 93. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shijiazhuang SIYAO Business Overview
Table 95. Shijiazhuang SIYAO Recent Developments
Table 96. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Basic Information
Table 97. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Overview
Table 98. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Yiling Pharmaceutical Business Overview
Table 100. Yiling Pharmaceutical Recent Developments
Table 101. Global Gliclazide Sustained-release Tablet Sales Forecast by Region (2025-2030) & (Kilotons)
Table 102. Global Gliclazide Sustained-release Tablet Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Gliclazide Sustained-release Tablet Sales Forecast by Country (2025-2030) & (Kilotons)
Table 104. North America Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Gliclazide Sustained-release Tablet Sales Forecast by Country (2025-2030) & (Kilotons)
Table 106. Europe Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Gliclazide Sustained-release Tablet Sales Forecast by Region (2025-2030) & (Kilotons)
Table 108. Asia Pacific Gliclazide Sustained-release Tablet Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Gliclazide Sustained-release Tablet Sales Forecast by Country (2025-2030) & (Kilotons)
Table 110. South America Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Gliclazide Sustained-release Tablet Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Gliclazide Sustained-release Tablet Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Gliclazide Sustained-release Tablet Sales Forecast by Type (2025-2030) & (Kilotons)
Table 114. Global Gliclazide Sustained-release Tablet Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Gliclazide Sustained-release Tablet Price Forecast by Type (2025-2030) & (USD/Ton)
Table 116. Global Gliclazide Sustained-release Tablet Sales (Kilotons) Forecast by Application (2025-2030)
Table 117. Global Gliclazide Sustained-release Tablet Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gliclazide Sustained-release Tablet
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gliclazide Sustained-release Tablet Market Size (M USD), 2019-2030
Figure 5. Global Gliclazide Sustained-release Tablet Market Size (M USD) (2019-2030)
Figure 6. Global Gliclazide Sustained-release Tablet Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gliclazide Sustained-release Tablet Market Size by Country (M USD)
Figure 11. Gliclazide Sustained-release Tablet Sales Share by Manufacturers in 2023
Figure 12. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers in 2023
Figure 13. Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gliclazide Sustained-release Tablet Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gliclazide Sustained-release Tablet Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gliclazide Sustained-release Tablet Market Share by Type
Figure 18. Sales Market Share of Gliclazide Sustained-release Tablet by Type (2019-2024)
Figure 19. Sales Market Share of Gliclazide Sustained-release Tablet by Type in 2023
Figure 20. Market Size Share of Gliclazide Sustained-release Tablet by Type (2019-2024)
Figure 21. Market Size Market Share of Gliclazide Sustained-release Tablet by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gliclazide Sustained-release Tablet Market Share by Application
Figure 24. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2019-2024)
Figure 25. Global Gliclazide Sustained-release Tablet Sales Market Share by Application in 2023
Figure 26. Global Gliclazide Sustained-release Tablet Market Share by Application (2019-2024)
Figure 27. Global Gliclazide Sustained-release Tablet Market Share by Application in 2023
Figure 28. Global Gliclazide Sustained-release Tablet Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2019-2024)
Figure 30. North America Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gliclazide Sustained-release Tablet Sales Market Share by Country in 2023
Figure 32. U.S. Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gliclazide Sustained-release Tablet Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gliclazide Sustained-release Tablet Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country in 2023
Figure 37. Germany Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gliclazide Sustained-release Tablet Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gliclazide Sustained-release Tablet Sales Market Share by Region in 2023
Figure 44. China Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gliclazide Sustained-release Tablet Sales and Growth Rate (Kilotons)
Figure 50. South America Gliclazide Sustained-release Tablet Sales Market Share by Country in 2023
Figure 51. Brazil Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gliclazide Sustained-release Tablet Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gliclazide Sustained-release Tablet Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gliclazide Sustained-release Tablet Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gliclazide Sustained-release Tablet Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gliclazide Sustained-release Tablet Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gliclazide Sustained-release Tablet Market Share Forecast by Type (2025-2030)
Figure 65. Global Gliclazide Sustained-release Tablet Sales Forecast by Application (2025-2030)
Figure 66. Global Gliclazide Sustained-release Tablet Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gliclazide Sustained-release Tablet
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gliclazide Sustained-release Tablet Market Size (M USD), 2019-2030
Figure 5. Global Gliclazide Sustained-release Tablet Market Size (M USD) (2019-2030)
Figure 6. Global Gliclazide Sustained-release Tablet Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gliclazide Sustained-release Tablet Market Size by Country (M USD)
Figure 11. Gliclazide Sustained-release Tablet Sales Share by Manufacturers in 2023
Figure 12. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers in 2023
Figure 13. Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gliclazide Sustained-release Tablet Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gliclazide Sustained-release Tablet Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gliclazide Sustained-release Tablet Market Share by Type
Figure 18. Sales Market Share of Gliclazide Sustained-release Tablet by Type (2019-2024)
Figure 19. Sales Market Share of Gliclazide Sustained-release Tablet by Type in 2023
Figure 20. Market Size Share of Gliclazide Sustained-release Tablet by Type (2019-2024)
Figure 21. Market Size Market Share of Gliclazide Sustained-release Tablet by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gliclazide Sustained-release Tablet Market Share by Application
Figure 24. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2019-2024)
Figure 25. Global Gliclazide Sustained-release Tablet Sales Market Share by Application in 2023
Figure 26. Global Gliclazide Sustained-release Tablet Market Share by Application (2019-2024)
Figure 27. Global Gliclazide Sustained-release Tablet Market Share by Application in 2023
Figure 28. Global Gliclazide Sustained-release Tablet Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2019-2024)
Figure 30. North America Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gliclazide Sustained-release Tablet Sales Market Share by Country in 2023
Figure 32. U.S. Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gliclazide Sustained-release Tablet Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gliclazide Sustained-release Tablet Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country in 2023
Figure 37. Germany Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gliclazide Sustained-release Tablet Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gliclazide Sustained-release Tablet Sales Market Share by Region in 2023
Figure 44. China Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gliclazide Sustained-release Tablet Sales and Growth Rate (Kilotons)
Figure 50. South America Gliclazide Sustained-release Tablet Sales Market Share by Country in 2023
Figure 51. Brazil Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gliclazide Sustained-release Tablet Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gliclazide Sustained-release Tablet Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gliclazide Sustained-release Tablet Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gliclazide Sustained-release Tablet Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gliclazide Sustained-release Tablet Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gliclazide Sustained-release Tablet Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gliclazide Sustained-release Tablet Market Share Forecast by Type (2025-2030)
Figure 65. Global Gliclazide Sustained-release Tablet Sales Forecast by Application (2025-2030)
Figure 66. Global Gliclazide Sustained-release Tablet Market Share Forecast by Application (2025-2030)